Session 895: Chemotherapy response

Date: 2 February 2004, Time: 14:00 - 16:00
Location: Room 1

Oral Presentations

Time	Number	Title / Authors / Affiliations
14:00	400	Predicting tumour response to Mitomycin C (MMC) in experimental tumour models and human superficial bladder cancer patients. RM Phillips PhD^a, S Basu MBBS MS FRCS^a, M Volpato BSc^a, AJ Scally PhD^b, R Puri MBBS MS FRCS^c, PM Loadman PhD^a ^aCancer Research Unit, Tom Connors Cancer Research Centre, Bradford, United Kingdom, ^bSchool of Health Studies, University of Bradford, Bradford, United Kingdom, ^cDepartment of Urology, St Lukes Hospital, Bradford, United Kingdom
14:20	401	Development of a novel class of agents that induce the degradation of Her2 G Chiosis PhD, M Vilenchik PhD, N Rosen MD PhD, D Solit MD Memorial Sloan-Kettering Cancer Center, New York, NY, United States
14:35	402	The Tyrphostin B42 inhibits cell proliferation and HER-2 autophosphorylation in cervical carcinoma cell lines PhD Soto-Cruz, R Rangel-Corona MSc, X Moreno-Morales BSc, R Santiago-Perez BSc, A Valle-Mendiola BSc, B Weiss-Steider PhD, JR Caceres-Cortes PhD Laboratory of Oncology, Research Unit in Cell Differentiation and Cancer, FES Zaragoza, UNAM, Mexico City, Mexico
14:50	403	DNA Strand Breaks In Peripheral Lymphocytes from Breast Cancer Patients before and after Chemotherapy. P Sánchez MS, D Vera MD, R Peñarroja DDS, F Gallegos MD, JL Bravo PhD, L Benítez-Bribiesca MD ^aOncological Research Unit, ^bDepartment of Clinical Oncology, National Medical Center S-XXI- IMSS; Oncology Hospital, C.P. México, D.F, ^cNational Autonomus University of Mexico, México, D.F. email: luisbenbri@mexis.com
15:05	404	EGFR Antagonism using ZD1839 (Iressa) Results in Increased Cytoxic Response to 5-FU in Colon Cancer Cells D Beech MD, N Deng MS University of Tennessee Health Science Center
15:20	405	Reorganization of actin in the nucleus of HL-60 and K-562 cell lines treated with cytostatic drugs. A Grzanka PhD^a,b, D Grzanka MD^b, D Smoliński PhD^c, M Orlikowska MSc^b ^aInstitute of Biology and Environment Protection, Kazimierz Wielki University, Bydgoszcz, Poland, ^bDepartment of Clinical Pathomorphology, The Ludwik Rydygier Medical University in Bydgoszcz, The Ludwik Rydygier Medical, Poland, ^cDepartment of Cell Biology, Nicolaus Copernicus University, Toruń, Poland